DAVID BOYER, MD
Ophthalmology Physician · LOS ANGELES, CA
Individual Active NPI 1295736916
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 2,440 | 91,510 | $23,426,487 | $8,005,425 | $6,277,649 |
| 2023 | 2,417 | 61,035 | $20,453,483 | $7,175,715 | $5,623,730 |
| 2022 | 2,352 | 29,058 | $16,874,938 | $5,690,270 | $4,439,953 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 55,080 | $35 | $27 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 12,345 | $147 | $116 |
| 92134 | Imaging of retina | 6,368 | $44 | $34 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 3,509 | $223 | $176 |
| 67028 | Injection of drug into eye | 3,224 | $136 | $108 |
| 92014 | Established patient complete exam of visual system | 3,004 | $139 | $101 |
| J0178 | Injection, aflibercept, 1 mg | 1,960 | $827 | $652 |
| 92012 | Established patient problem focused exam of visual system | 866 | $99 | $75 |
| J2778 | Injection, ranibizumab, 0.1 mg | 675 | $161 | $123 |
| J0177 | Injection, aflibercept hd, 1 mg | 632 | $332 | $265 |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 483 | $54 | $43 |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 413 | $202 | $160 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | G25107 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in California
- NPI 1962412643
- NPI 1679758544
- NPI 1992992945
- NPI 1073816070
- NPI 1942369699
- NPI 1295000693
- NPI 1073730081
- NPI 1801390216
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.